Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

86.60 1.50 −1.70%
Market cap
$50.8B
P/E
49.8×
Fwd P/E
30.7×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a

Edwards Lifesciences Corporation (EW) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Edwards Lifesciences Corporation (EW) trades at a P/B ratio of 4.7×. Over the past ten years it has ranged from 3.9× (April 2025) to 14.9× (September 2021); the current reading is higher than 12% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 4.8× 9.68%
FY2024 4.4× (35.56%)
FY2023 6.8× (13.82%)
FY2022 7.9× (42.78%)
FY2021 13.8× 11.43%
FY2020 12.4× 6.02%
FY2019 11.7× 14.78%
FY2018 10.2× 28.20%
FY2017 8.0× 2.46%
FY2016 7.8× 14.23%

Quarterly newest first

Period P/B ratio Change
Jun 2026 4.9× 8.25%
Mar 2026 4.5× (6.87%)
Dec 2025 4.8× 8.23%
Sep 2025 4.5× 2.95%
42 more quarters

Against its own ten years

Low 3.9× High 14.9×
Ten-year median 8.4×
Current reading's percentile 13

P/B ratio against peers

Company P/B ratio
ZBH Zimmer Biomet Holdings, Inc. compare 1.4×
PHG Koninklijke Philips N.V. compare 1.8×
MDT Medtronic PLC compare 2.4×
BSX Boston Scientific Corporation compare 2.6×
GEHC GE HealthCare Technologies Inc. compare 2.9×
STE STERIS plc compare 3.0×
EW Edwards Lifesciences Corporation 4.7×
SYK Stryker Corporation compare 4.7×
DXCM DexCom, Inc. compare 12.5×
Medical Devices industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on EW